Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Recruiting Observational Study
Chronic Kidney Diseases Type 2 Diabetes Mellitus Arterial Hypertension Obesity Cardiovascular Diseases HIV Infections Anemia Underweight Infections Albuminuria Dyslipidemias
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 99
Sex
Any
Study type
Observational
Participants needed
1,200 (estimated)
Sponsor
Swiss Tropical & Public Health Institute · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality. The prevalence of CKD is increasing worldwide and is assumed to also dramatically increase in Sub-Saharan Africa (SSA). Key shortcomings of available data on CKD in SSA are as follows: (i) Available data are based on single measurements and, therefore, cannot distinguish between harmless transient det…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: all adult patients (≥18 years) attending the outpatients department of the Bagamoyo district hospital (BDH) or the associated Fukayosi and Yombo dispensary Exclusion Criteria: * \<18 years of age * not living in the BDH catchment area * not of African decent * not willing to c…
Contacts

Nikolai C Hodel, MSc

+255762768035

nikolai.hodel@swisstph.ch

CONTACT

Ally Olotu, PhD

+255718927104

aolotu@ihi.or.tz

CONTACT